GlassScriptPhysician profile
David John Homan
NPI 1164681334
$90,124.57
in general payments reported to CMS, 2019-2025
52 companies · $4,337 in 2025
The $4,337 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,237 · 2020: $368 · 2021: $855 · 2022: $4,151 · 2023: $18K · 2024: $60K · 2025: $4,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $59K · Travel and Lodging: $9,534 · Food and Beverage: $7,150 · Long Term Medical Supply Or Device Loan: $6,380 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,950.00 |
| Travel and Lodging | $9,533.62 |
| Food and Beverage | $7,149.55 |
| Long Term Medical Supply Or Device Loan | $6,380.00 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $55,187.61 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $17,161.48 | 2022-2023 | Arcalyst |
| Angiodynamics, INC. | $6,967.38 | 2022-2025 | Venacure 1470 Pro, Auryon Laser System 100-120 Vac, Alphavac |
| Boston Scientific Corporation | $1,360.61 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr, Mylux Patient Kit With Mobile Device |
| Abiomed | $856.88 | 2019-2025 | Impella |
| Inari Medical, INC. | $776.97 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $746.28 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $631.94 | 2019-2025 | |
| Novo Nordisk INC | $607.96 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Kestra Medical Technology Services, INC. | $554.79 | 2025 | Assure Wcd |
| Medtronic, INC. | $547.13 | 2021-2025 | In.Pact Admiral, Hawkone, Abre |
| Abbott Laboratories | $543.80 | 2019-2025 | Diamondback Coronary, Jot Dx, Cardiomems |
| Becton, Dickinson and Company | $522.44 | 2023-2024 | Venclose Maven Catheter |
| Shockwave Medical, INC | $454.74 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $417.53 | 2019-2023 | Diamondback Peripheral |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Homan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.